Published Scientific Evidence
Category: (Cardiac Amyloidosis)
Anumana’s ECG-AI™ technology is supported by one of the most extensive evidence bases in cardiovascular AI. This library provides direct access to our peer-reviewed validation studies and broader body of clinical research.
August
30
2024
August 30, 2024
Wiley Online Library
Predictors of mortality by an artificial intelligence enhanced electrocardiogram model for cardiac amyloidosis
Aims: We aim to determine if our previously validated, diagnostic artificial intelligence (AI) electrocardiogram (ECG) model is prognostic for survival among patients with cardiac amyloidosis (CA). Methods: A total of…